Faulty Antibodies Undermine Widespread Research
Faulty Antibodies Undermine Widespread Research
Two papers reveal that many commonly used research antibodies don’t bind as believed, highlighting the need to validate these reagents before use.
Faulty Antibodies Undermine Widespread Research
Faulty Antibodies Undermine Widespread Research

Two papers reveal that many commonly used research antibodies don’t bind as believed, highlighting the need to validate these reagents before use.

Two papers reveal that many commonly used research antibodies don’t bind as believed, highlighting the need to validate these reagents before use.

best practices
Shoddy Preclinical Data Used in Clinical Trial Proposals
Shoddy Preclinical Data Used in Clinical Trial Proposals
Kerry Grens | Apr 5, 2018
Applications for Phase 1 and 2 human studies in Germany frequently lack sufficient information about an intervention’s efficacy in animal experiments, according to a new study.